Holbrook Kerr (CIK 1861246) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-11-19). Recent activity: Sell AVNS (13,834 shares), Sell AVNS (100 shares), Sell AVNS (761 shares), Sell AVNS (305 shares), Buy AVNS (22,877 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-19 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Sell | 13,834 | $152,174 |
| 2025-11-19 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Sell | 100 | $1,101 |
| 2025-11-19 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Sell | 761 | $8,379 |
| 2025-11-19 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Sell | 305 | $3,361 |
| 2025-03-11 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Buy | 22,877 | $0 |
| 2025-03-10 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Sell | 7,000 | $106,750 |
| 2025-03-10 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Sell | 2,474 | $37,852 |
| 2025-03-10 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Sell | 3,590 | $54,927 |
| 2025-03-06 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Buy | 5,145 | $0 |
| 2025-03-06 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Sell | 1,803 | $27,279 |
| 2025-03-06 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Commercial Officer | Sell | 1,543 | $23,346 |
Source: SEC Form 4 filings · as of 2025-11-19